BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7751879)

  • 41. Primary neutrophil-rich, CD30-positive anaplastic large cell lymphoma of the stomach: case report and review of the literature.
    Kahaleh M; Hermans P; Buset M; Dargent JL
    Acta Gastroenterol Belg; 2002; 65(4):237-40. PubMed ID: 12619433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
    Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
    J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin's B cell lymphoma.
    Breen EC; Fatahi S; Epeldegui M; Boscardin WJ; Detels R; Martínez-Maza O
    Tumour Biol; 2006; 27(4):187-94. PubMed ID: 16651853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].
    Vinogradova IuE; Lutsenko IN; Kaplanskaia IB; Vorob'ev IA; Samoĭlova RS; Gorgidze LA; Ryzhikova NA; Valiev TT; Giliazitdinova EA; Dzhulakian UL; Egorova EK; Zvonkov EE; Krasil'nikova BB; Magomedova AU; Margolin OV; Mar'in DS; Kremenetskaia AM; Kravchenko SK; Vorob'ev AI
    Ter Arkh; 2008; 80(7):33-7. PubMed ID: 18763592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
    Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
    J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection?
    Altermann W; Schlaf G; Rothhoff A; Seliger B
    Nephrol Dial Transplant; 2007 Oct; 22(10):2795-9. PubMed ID: 17616534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic, cytogenetic, and molecular studies of 13 Chinese Patients with Ki-1 anaplastic large cell lymphoma. Special emphasis on the tumor response to 13-cis retinoic acid.
    Chou WC; Su IJ; Tien HF; Liang DC; Wang CH; Chang YC; Cheng AL
    Cancer; 1996 Oct; 78(8):1805-12. PubMed ID: 8859196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinico-morphologic reconsideration of anaplastic lymphoma. Retrospective study of 60 patients with aggressive clinical course and multiple recurrences].
    Ageitos AG; Rivas C; Lobo F; Obeso G; Marcos B; Gonzalo I; Echezarreta G; Delgado RG; Oliva H
    Rev Clin Esp; 1996 Dec; 196(12):821-7. PubMed ID: 9132858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
    Kumar S; Pittaluga S; Raffeld M; Guerrera M; Seibel NL; Jaffe ES
    Pediatr Dev Pathol; 2005; 8(1):52-60. PubMed ID: 15719203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two cases of CD30+, anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with oral manifestations.
    Grandhi A; Boros AL; Berardo N; Reich RF; Freedman PD
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):e41-7. PubMed ID: 22940020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haptoglobin-related protein as a serum marker in malignant lymphoma.
    Epelbaum R; Shalitin C; Segal R; Valansi C; Arselan I; Faraggi D; Leviov M; Ben-Shahar M; Haim N
    Pathol Oncol Res; 1998; 4(4):271-6. PubMed ID: 9887357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum soluble CD30 in early arthritis: a sign of inflammation but not a predictor of outcome.
    Savolainen E; Matinlauri I; Kautiainen H; Luosujärvi R; Kaipiainen-Seppänen O
    Clin Exp Rheumatol; 2008; 26(5):922-5. PubMed ID: 19032830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
    Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
    J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.
    Schnell R; Staak O; Borchmann P; Schwartz C; Matthey B; Hansen H; Schindler J; Ghetie V; Vitetta ES; Diehl V; Engert A
    Clin Cancer Res; 2002 Jun; 8(6):1779-86. PubMed ID: 12060617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating soluble-CD30 (sCD30) in patients with HCV-related chronic hepatitis and in patients with alcoholic liver disease.
    De Lazzari F; Ravagnan P; Tenderini M; Vicarioto MA; Galliani EA; Lorenzoni U; Popovic A; Floreani A
    Hepatogastroenterology; 2002; 49(43):231-4. PubMed ID: 11941962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity.
    Caligaris-Cappio F; Bertero MT; Converso M; Stacchini A; Vinante F; Romagnani S; Pizzolo G
    Clin Exp Rheumatol; 1995; 13(3):339-43. PubMed ID: 7554561
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.
    Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N
    J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma.
    Janik JE; Morris JC; Pittaluga S; McDonald K; Raffeld M; Jaffe ES; Grant N; Gutierrez M; Waldmann TA; Wilson WH
    Blood; 2004 Nov; 104(10):3355-7. PubMed ID: 15205267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The relation between clinical features of adult T-cell leukemia/lymphoma and the serum levels of soluble CD25 and CD30].
    Takemoto S; Pornkuna R; Hidaka M; Kawano F
    Rinsho Ketsueki; 2016 Jul; 57(7):848-53. PubMed ID: 27498727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD30 antigen in non-Hodgkin's lymphoma.
    Miyake K; Yoshino T; Sarker AB; Teramoto N; Akagi T
    Pathol Int; 1994 Jun; 44(6):428-34. PubMed ID: 8055109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.